UY27824A1 - Nueva formulación para la administración parenteral de crobenetina. - Google Patents
Nueva formulación para la administración parenteral de crobenetina.Info
- Publication number
- UY27824A1 UY27824A1 UY27824A UY27824A UY27824A1 UY 27824 A1 UY27824 A1 UY 27824A1 UY 27824 A UY27824 A UY 27824A UY 27824 A UY27824 A UY 27824A UY 27824 A1 UY27824 A1 UY 27824A1
- Authority
- UY
- Uruguay
- Prior art keywords
- parenteral administration
- crobenetine
- new formulation
- new
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a una nueva formulación que contiene crobenetina o una de sus sales farmacéuticamente aceptables, para administración por vía parenteral.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10223784A DE10223784A1 (de) | 2002-05-29 | 2002-05-29 | Neue Formulierung zur parenteralen Applikation von Crobenetine |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27824A1 true UY27824A1 (es) | 2003-12-31 |
Family
ID=29432394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27824A UY27824A1 (es) | 2002-05-29 | 2003-05-27 | Nueva formulación para la administración parenteral de crobenetina. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1511487A1 (es) |
JP (1) | JP2005531573A (es) |
AR (1) | AR040135A1 (es) |
AU (1) | AU2003240699A1 (es) |
CA (1) | CA2487153A1 (es) |
DE (1) | DE10223784A1 (es) |
PE (1) | PE20040067A1 (es) |
TW (1) | TW200406205A (es) |
UY (1) | UY27824A1 (es) |
WO (1) | WO2003099280A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10223783A1 (de) * | 2002-05-29 | 2003-12-11 | Boehringer Ingelheim Pharma | Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers |
-
2002
- 2002-05-29 DE DE10223784A patent/DE10223784A1/de not_active Withdrawn
-
2003
- 2003-05-23 WO PCT/EP2003/005400 patent/WO2003099280A1/de not_active Application Discontinuation
- 2003-05-23 CA CA002487153A patent/CA2487153A1/en not_active Abandoned
- 2003-05-23 EP EP03730101A patent/EP1511487A1/de not_active Withdrawn
- 2003-05-23 AU AU2003240699A patent/AU2003240699A1/en not_active Abandoned
- 2003-05-23 JP JP2004506804A patent/JP2005531573A/ja active Pending
- 2003-05-27 TW TW092114284A patent/TW200406205A/zh unknown
- 2003-05-27 PE PE2003000512A patent/PE20040067A1/es not_active Application Discontinuation
- 2003-05-27 UY UY27824A patent/UY27824A1/es not_active Application Discontinuation
- 2003-05-28 AR ARP030101864A patent/AR040135A1/es not_active Suspension/Interruption
Also Published As
Publication number | Publication date |
---|---|
AU2003240699A1 (en) | 2003-12-12 |
EP1511487A1 (de) | 2005-03-09 |
JP2005531573A (ja) | 2005-10-20 |
TW200406205A (en) | 2004-05-01 |
PE20040067A1 (es) | 2004-03-30 |
CA2487153A1 (en) | 2003-12-04 |
AR040135A1 (es) | 2005-03-16 |
WO2003099280A1 (de) | 2003-12-04 |
DE10223784A1 (de) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113003T1 (el) | Ευσταθη παρασκευασματα laquinimod | |
SV2004001690A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
HN2003000407A (es) | Nuevos derivados de fluoroglicosisdos aromaticos, medicamentos que contienen estos compuestos y sus usos. | |
AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
UY28348A1 (es) | Compuestos novedosos | |
ECSP055786A (es) | Derivados de ciclohexano espirocíclicos | |
HN2006019066A (es) | "(s)-n-metilnaltrexona" | |
ECSP045491A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
ECSP045221A (es) | Sales de valsartan | |
ECSP066291A (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
HN2004000109A (es) | Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
CO5700723A2 (es) | Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca | |
CR7648A (es) | Microcapsulas para la liberacion retardada y controlada del perindropil | |
ECSP066292A (es) | Sistemas semi-sólidos que contienen derivados de azetidina | |
UY27824A1 (es) | Nueva formulación para la administración parenteral de crobenetina. | |
UY27620A1 (es) | Ambroxoll para el tratamiento de dolores crónicos | |
ITRM20030074A0 (it) | Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci. | |
ECSP034708A (es) | Nueva sal de benzoilguanidina | |
UY27823A1 (es) | Nueva formulación para la administración parenteral de un bloqueante del canal del na | |
GT199800008A (es) | Procedimiento para la preparacion de un derivado de tetrahidropiridina. | |
CL2003002077A1 (es) | Uso de una composicion farmaceutica que comprende un inhibidor de la recaptacion de norepinefrina seleccionado entre maprotilina, norpramina, desipramina, nisoxetina, atomoxetina, amoxapina, dexepina, lofepramina, amitriptilina, entre otros, para tra | |
HN1999000128A (es) | Nuevos usos farmaceuticos para inhibidores nos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150223 |